Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$11.00 -1.6%	$12.11	$10.86 ▼ $25.36	$516.54M	1.12	434,917 shs	670,789 shs
AXGN AxoGen	$12.67 -3.2%	$11.22	$7.34 ▼ $21.00	$596.17M	1	1.39 million shs	1.56 million shs
BVS Bioventus	$6.18 -5.2%	$6.65	$6.02 ▼ $14.38	$507.65M	0.84	383,242 shs	526,076 shs
LAKE Lakeland Industries	$13.35 -4.0%	$15.04	$12.76 ▼ $27.28	$132.35M	1.01	126,216 shs	108,701 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	-1.48%	-8.44%	-10.96%	-10.46%	-53.92%
AXGN AxoGen	-3.21%	-5.24%	+14.56%	-26.04%	+44.31%
BVS Bioventus	-5.21%	-5.94%	-9.78%	-15.80%	-11.84%
LAKE Lakeland Industries	-4.03%	-10.76%	-2.20%	-20.72%	-43.43%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVNS AVANOS MEDICAL	2.9208 of 5 stars	0.0	5.0	0.0	0.0	2.2	1.7	2.5
AXGN AxoGen	2.3335 of 5 stars	3.5	1.0	0.0	0.0	2.5	2.5	0.6
BVS Bioventus	3.1628 of 5 stars	3.4	0.0	0.0	0.0	2.6	3.3	1.3
LAKE Lakeland Industries	4.7438 of 5 stars	3.5	1.0	0.8	4.9	2.3	3.3	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	0.00	N/A	N/A	N/A
AXGN AxoGen	3.00	Buy	$24.50	93.37% Upside
BVS Bioventus	2.75	Moderate Buy	$13.75	122.49% Upside
LAKE Lakeland Industries	3.00	Buy	$26.00	94.76% Upside

Current Analyst Ratings Breakdown

Latest LAKE, AVNS, BVS, and AXGN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/7/2025	BVS Bioventus	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$12.00
6/10/2025	LAKE Lakeland Industries	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$30.00 ➝ $26.00
5/13/2025	AXGN AxoGen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$26.00 ➝ $24.00
5/7/2025	BVS Bioventus	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$15.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$687.80M	0.74	$11.70 per share	0.94	$18.03 per share	0.61
AXGN AxoGen	$187.34M	3.08	N/A	N/A	$2.36 per share	5.37
BVS Bioventus	$567.70M	0.89	$0.49 per share	12.58	$2.80 per share	2.21
LAKE Lakeland Industries	$177.65M	0.72	$1.02 per share	13.03	$15.44 per share	0.86

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$392.10M	-$8.37	N/A	6.36	N/A	-55.80%	6.26%	4.63%	8/5/2025 (Estimated)
AXGN AxoGen	-$9.96M	-$0.15	N/A	N/A	N/A	-3.68%	-7.09%	-3.67%	8/5/2025 (Estimated)
BVS Bioventus	-$156.23M	-$0.48	N/A	13.43	N/A	-7.11%	15.61%	4.01%	N/A
LAKE Lakeland Industries	-$18.08M	-$3.01	N/A	8.04	N/A	-13.31%	-6.88%	-4.47%	9/3/2025 (Estimated)

Latest LAKE, AVNS, BVS, and AXGN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	AVNS Avanos Medical	$0.18	N/A	N/A	N/A	$165.50 million	N/A
8/5/2025	Q2 2025	AXGN AxoGen	$0.06	N/A	N/A	N/A	$52.61 million	N/A
6/9/2025	Q1 2026	LAKE Lakeland Industries	$0.27	-$0.41	-$0.68	-$0.41	$48.84 million	$46.75 million
5/6/2025	Q1 2025	AVNS Avanos Medical	$0.19	$0.26	+$0.07	$0.14	$161.75 million	$167.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
AXGN AxoGen	N/A	N/A	N/A	N/A	N/A
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
LAKE Lakeland Industries	$0.12	0.90%	N/A	N/A	1 Years

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS AVANOS MEDICAL	0.12	2.57	1.56
AXGN AxoGen	0.63	4.28	2.65
BVS Bioventus	1.85	1.41	0.99
LAKE Lakeland Industries	0.17	3.88	1.51

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
AXGN AxoGen	80.29%
BVS Bioventus	62.94%
LAKE Lakeland Industries	71.69%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.64%
AXGN AxoGen	2.78%
BVS Bioventus	33.00%
LAKE Lakeland Industries	1.91%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	2,227	46.24 million	45.02 million	Optionable
AXGN AxoGen	450	45.54 million	44.28 million	Optionable
BVS Bioventus	1,200	82.14 million	54.46 million	Not Optionable
LAKE Lakeland Industries	2,100	9.52 million	9.33 million	Optionable

LAKE, AVNS, BVS, and AXGN Headlines

Recent News About These Companies

Lakeland Fire + Safety Declares Cash Dividend for Third Quarter 2026

August 1 at 4:17 PM | globenewswire.com

Lakeland Industries, Inc. (NASDAQ:LAKE) Shares Bought by Royce & Associates LP

July 25, 2025 | marketbeat.com

Lakeland Industries, Inc. (LAKE): A Bull Case Theory

July 24, 2025 | finance.yahoo.com

Lakeland Fire + Safety’s Jolly Scarpe Ships $3.1 Million Fire Boot Order with Italian Government

July 23, 2025 | finance.yahoo.com

Veridian Fire Protective Gear in Quitman to close

July 23, 2025 | nwaonline.comN

Lakeland Fire + Safety Announces Closure of Hull, UK and Quitman, Arkansas Facilities as Part of Strategic Consolidation Plan

July 23, 2025 | finance.yahoo.com

Lakeland Fire + Safety Announces Closure of Hull, UK and Quitman, Arkansas Facilities as Part ...

July 21, 2025 | bakersfield.comB

Lakeland Industries, Inc. (NASDAQ:LAKE) is a favorite amongst institutional investors who own 71%

July 18, 2025 | finance.yahoo.com

Lakeland Industries, Inc. (LAKE) - Yahoo Finance

July 4, 2025 | finance.yahoo.com

Lakeland Industries added to Russell 3000 and 2000 indexes

July 2, 2025 | investing.com

Lakeland Industries, Inc. Added to Russell 3000® and Russell 2000® Indexes Following Annual Reconstitution

June 30, 2025 | quiverquant.comQ

Lakeland Fire + Safety Added to Russell 3000® and Russell 2000® Indexes

June 30, 2025 | globenewswire.com

LAKE Lakeland Industries, Inc. - Seeking Alpha

June 26, 2025 | seekingalpha.com

Lakeland Industries: Challenging Q1 2026 Might Provide Opportunity If You Believe In Management

June 25, 2025 | seekingalpha.com

LAKE - Lakeland Industries Inc Executives - Morningstar

June 24, 2025 | morningstar.comM

Lakeland Industries CEO Jenkins buys $13,140 in Lake stock

June 22, 2025 | investing.com

Insider Buying: Lakeland Industries, Inc. (NASDAQ:LAKE) CEO Buys 1,000 Shares of Stock

June 21, 2025 | insidertrades.com

Lakeland Industries reports annual meeting results

June 15, 2025 | investing.com

Lakeland Industries reports annual meeting results

June 15, 2025 | investing.com

Lakeland Industries, Inc. Management to Attend 15th Annual ROTH London Conference for Investor Meetings

June 12, 2025 | quiverquant.comQ

Lakeland Fire + Safety to Attend the 15th Annual ROTH London Conference

June 12, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LAKE, AVNS, BVS, and AXGN Company Descriptions

Avanos Medical NYSE:AVNS

$11.00 -0.18 (-1.57%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$11.26 +0.27 (+2.41%)

As of 08/1/2025 05:57 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

AxoGen NASDAQ:AXGN

$12.67 -0.42 (-3.21%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$12.71 +0.04 (+0.28%)

As of 08/1/2025 06:27 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Bioventus NYSE:BVS

$6.18 -0.34 (-5.21%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$6.18 0.00 (0.00%)

As of 08/1/2025 07:47 PM Eastern

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Lakeland Industries NASDAQ:LAKE

$13.35 -0.56 (-4.03%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$13.36 +0.01 (+0.04%)

As of 08/1/2025 04:04 PM Eastern

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time